nodes	percent_of_prediction	percent_of_DWPC	metapath
Clofarabine—ABCG2—Rosuvastatin—atherosclerosis	0.242	0.344	CbGbCtD
Clofarabine—ABCG2—Ezetimibe—atherosclerosis	0.242	0.344	CbGbCtD
Clofarabine—ABCG2—Pravastatin—atherosclerosis	0.22	0.313	CbGbCtD
Clofarabine—DCK—Simvastatin—Pravastatin—atherosclerosis	0.00403	0.5	CbGdCrCtD
Clofarabine—DCK—Simvastatin—Lovastatin—atherosclerosis	0.00403	0.5	CbGdCrCtD
Clofarabine—Gastrointestinal haemorrhage—Niacin—atherosclerosis	0.00137	0.00531	CcSEcCtD
Clofarabine—Sinusitis—Rosuvastatin—atherosclerosis	0.00136	0.00527	CcSEcCtD
Clofarabine—Influenza—Ezetimibe—atherosclerosis	0.00135	0.00524	CcSEcCtD
Clofarabine—Pancreatitis—Lovastatin—atherosclerosis	0.00135	0.00523	CcSEcCtD
Clofarabine—Toxic epidermal necrolysis—Simvastatin—atherosclerosis	0.00134	0.0052	CcSEcCtD
Clofarabine—Pancreatitis—Ezetimibe—atherosclerosis	0.00132	0.00513	CcSEcCtD
Clofarabine—Pancreatitis—Simvastatin—atherosclerosis	0.00126	0.0049	CcSEcCtD
Clofarabine—Upper respiratory tract infection—Ezetimibe—atherosclerosis	0.00126	0.00487	CcSEcCtD
Clofarabine—Dry skin—Niacin—atherosclerosis	0.00125	0.00486	CcSEcCtD
Clofarabine—Dry skin—Pravastatin—atherosclerosis	0.00123	0.00479	CcSEcCtD
Clofarabine—Stevens-Johnson syndrome—Lovastatin—atherosclerosis	0.00122	0.00472	CcSEcCtD
Clofarabine—Toxic epidermal necrolysis—Pravastatin—atherosclerosis	0.00121	0.0047	CcSEcCtD
Clofarabine—Infestation NOS—Ezetimibe—atherosclerosis	0.0012	0.00467	CcSEcCtD
Clofarabine—Infestation—Ezetimibe—atherosclerosis	0.0012	0.00467	CcSEcCtD
Clofarabine—Neuropathy peripheral—Lovastatin—atherosclerosis	0.0012	0.00467	CcSEcCtD
Clofarabine—Upper respiratory tract infection—Simvastatin—atherosclerosis	0.0012	0.00464	CcSEcCtD
Clofarabine—Alanine aminotransferase increased—Pravastatin—atherosclerosis	0.00119	0.00461	CcSEcCtD
Clofarabine—Influenza—Niacin—atherosclerosis	0.00118	0.00459	CcSEcCtD
Clofarabine—Neuropathy peripheral—Ezetimibe—atherosclerosis	0.00118	0.00458	CcSEcCtD
Clofarabine—Jaundice—Ezetimibe—atherosclerosis	0.00117	0.00455	CcSEcCtD
Clofarabine—Influenza—Pravastatin—atherosclerosis	0.00116	0.00451	CcSEcCtD
Clofarabine—Sinusitis—Lovastatin—atherosclerosis	0.00115	0.00447	CcSEcCtD
Clofarabine—Pancreatitis—Pravastatin—atherosclerosis	0.00114	0.00443	CcSEcCtD
Clofarabine—Mental disorder—Rosuvastatin—atherosclerosis	0.00114	0.00442	CcSEcCtD
Clofarabine—Hepatobiliary disease—Ezetimibe—atherosclerosis	0.00114	0.00442	CcSEcCtD
Clofarabine—Stevens-Johnson syndrome—Simvastatin—atherosclerosis	0.00114	0.00441	CcSEcCtD
Clofarabine—Sinusitis—Ezetimibe—atherosclerosis	0.00113	0.00438	CcSEcCtD
Clofarabine—Neuropathy peripheral—Simvastatin—atherosclerosis	0.00113	0.00436	CcSEcCtD
Clofarabine—Jaundice—Simvastatin—atherosclerosis	0.00112	0.00434	CcSEcCtD
Clofarabine—Upper respiratory tract infection—Pravastatin—atherosclerosis	0.00108	0.0042	CcSEcCtD
Clofarabine—Sinusitis—Simvastatin—atherosclerosis	0.00108	0.00418	CcSEcCtD
Clofarabine—Oedema peripheral—Ezetimibe—atherosclerosis	0.00106	0.00413	CcSEcCtD
Clofarabine—Connective tissue disorder—Ezetimibe—atherosclerosis	0.00106	0.00412	CcSEcCtD
Clofarabine—Weight decreased—Pravastatin—atherosclerosis	0.00105	0.00408	CcSEcCtD
Clofarabine—Erythema multiforme—Lovastatin—atherosclerosis	0.00104	0.00404	CcSEcCtD
Clofarabine—Stevens-Johnson syndrome—Pravastatin—atherosclerosis	0.00103	0.00399	CcSEcCtD
Clofarabine—Stomatitis—Niacin—atherosclerosis	0.00103	0.00399	CcSEcCtD
Clofarabine—Jaundice—Niacin—atherosclerosis	0.00103	0.00399	CcSEcCtD
Clofarabine—Flushing—Lovastatin—atherosclerosis	0.00102	0.00397	CcSEcCtD
Clofarabine—Erythema multiforme—Ezetimibe—atherosclerosis	0.00102	0.00396	CcSEcCtD
Clofarabine—Neuropathy peripheral—Pravastatin—atherosclerosis	0.00102	0.00395	CcSEcCtD
Clofarabine—Jaundice—Pravastatin—atherosclerosis	0.00101	0.00392	CcSEcCtD
Clofarabine—Flushing—Ezetimibe—atherosclerosis	0.001	0.00389	CcSEcCtD
Clofarabine—Chills—Lovastatin—atherosclerosis	0.000989	0.00383	CcSEcCtD
Clofarabine—Cough—Rosuvastatin—atherosclerosis	0.000988	0.00383	CcSEcCtD
Clofarabine—Angiopathy—Ezetimibe—atherosclerosis	0.000981	0.0038	CcSEcCtD
Clofarabine—Immune system disorder—Ezetimibe—atherosclerosis	0.000976	0.00379	CcSEcCtD
Clofarabine—Erythema multiforme—Simvastatin—atherosclerosis	0.000975	0.00378	CcSEcCtD
Clofarabine—Mediastinal disorder—Ezetimibe—atherosclerosis	0.000974	0.00378	CcSEcCtD
Clofarabine—Sinusitis—Pravastatin—atherosclerosis	0.000974	0.00378	CcSEcCtD
Clofarabine—Alopecia—Lovastatin—atherosclerosis	0.000974	0.00378	CcSEcCtD
Clofarabine—Myalgia—Rosuvastatin—atherosclerosis	0.000964	0.00374	CcSEcCtD
Clofarabine—Arthralgia—Rosuvastatin—atherosclerosis	0.000964	0.00374	CcSEcCtD
Clofarabine—Flushing—Simvastatin—atherosclerosis	0.000957	0.00371	CcSEcCtD
Clofarabine—Alopecia—Ezetimibe—atherosclerosis	0.000955	0.0037	CcSEcCtD
Clofarabine—Haemoglobin—Niacin—atherosclerosis	0.000951	0.00369	CcSEcCtD
Clofarabine—Mental disorder—Ezetimibe—atherosclerosis	0.000947	0.00367	CcSEcCtD
Clofarabine—Haemorrhage—Niacin—atherosclerosis	0.000947	0.00367	CcSEcCtD
Clofarabine—Erythema—Ezetimibe—atherosclerosis	0.000941	0.00365	CcSEcCtD
Clofarabine—Malnutrition—Ezetimibe—atherosclerosis	0.000941	0.00365	CcSEcCtD
Clofarabine—Oedema peripheral—Niacin—atherosclerosis	0.000932	0.00362	CcSEcCtD
Clofarabine—Back pain—Lovastatin—atherosclerosis	0.000928	0.0036	CcSEcCtD
Clofarabine—Chills—Simvastatin—atherosclerosis	0.000925	0.00359	CcSEcCtD
Clofarabine—Infection—Rosuvastatin—atherosclerosis	0.000918	0.00356	CcSEcCtD
Clofarabine—Alopecia—Simvastatin—atherosclerosis	0.000911	0.00353	CcSEcCtD
Clofarabine—Back pain—Ezetimibe—atherosclerosis	0.00091	0.00353	CcSEcCtD
Clofarabine—Nervous system disorder—Rosuvastatin—atherosclerosis	0.000906	0.00351	CcSEcCtD
Clofarabine—Thrombocytopenia—Rosuvastatin—atherosclerosis	0.000905	0.00351	CcSEcCtD
Clofarabine—Mental disorder—Simvastatin—atherosclerosis	0.000903	0.0035	CcSEcCtD
Clofarabine—Tremor—Lovastatin—atherosclerosis	0.000899	0.00349	CcSEcCtD
Clofarabine—Erythema—Simvastatin—atherosclerosis	0.000897	0.00348	CcSEcCtD
Clofarabine—Erythema multiforme—Pravastatin—atherosclerosis	0.000881	0.00342	CcSEcCtD
Clofarabine—Flushing—Niacin—atherosclerosis	0.000878	0.00341	CcSEcCtD
Clofarabine—Anaemia—Ezetimibe—atherosclerosis	0.00087	0.00337	CcSEcCtD
Clofarabine—Flushing—Pravastatin—atherosclerosis	0.000865	0.00335	CcSEcCtD
Clofarabine—Cardiac disorder—Pravastatin—atherosclerosis	0.000865	0.00335	CcSEcCtD
Clofarabine—Angiopathy—Niacin—atherosclerosis	0.000859	0.00333	CcSEcCtD
Clofarabine—Leukopenia—Lovastatin—atherosclerosis	0.000859	0.00333	CcSEcCtD
Clofarabine—Chills—Niacin—atherosclerosis	0.000849	0.00329	CcSEcCtD
Clofarabine—Musculoskeletal discomfort—Rosuvastatin—atherosclerosis	0.000842	0.00326	CcSEcCtD
Clofarabine—Tremor—Simvastatin—atherosclerosis	0.000841	0.00326	CcSEcCtD
Clofarabine—Alopecia—Niacin—atherosclerosis	0.000836	0.00324	CcSEcCtD
Clofarabine—Chills—Pravastatin—atherosclerosis	0.000836	0.00324	CcSEcCtD
Clofarabine—Paraesthesia—Rosuvastatin—atherosclerosis	0.00083	0.00322	CcSEcCtD
Clofarabine—Anaemia—Simvastatin—atherosclerosis	0.000829	0.00322	CcSEcCtD
Clofarabine—Malnutrition—Niacin—atherosclerosis	0.000824	0.0032	CcSEcCtD
Clofarabine—Erythema—Niacin—atherosclerosis	0.000824	0.0032	CcSEcCtD
Clofarabine—Alopecia—Pravastatin—atherosclerosis	0.000824	0.00319	CcSEcCtD
Clofarabine—Cough—Ezetimibe—atherosclerosis	0.000821	0.00318	CcSEcCtD
Clofarabine—Arthralgia—Lovastatin—atherosclerosis	0.000817	0.00317	CcSEcCtD
Clofarabine—Myalgia—Lovastatin—atherosclerosis	0.000817	0.00317	CcSEcCtD
Clofarabine—Anxiety—Lovastatin—atherosclerosis	0.000814	0.00316	CcSEcCtD
Clofarabine—Hypertension—Ezetimibe—atherosclerosis	0.000812	0.00315	CcSEcCtD
Clofarabine—Leukopenia—Simvastatin—atherosclerosis	0.000803	0.00311	CcSEcCtD
Clofarabine—Arthralgia—Ezetimibe—atherosclerosis	0.000801	0.00311	CcSEcCtD
Clofarabine—Myalgia—Ezetimibe—atherosclerosis	0.000801	0.00311	CcSEcCtD
Clofarabine—Unspecified disorder of skin and subcutaneous tissue—Ezetimibe—atherosclerosis	0.000796	0.00309	CcSEcCtD
Clofarabine—Pain—Rosuvastatin—atherosclerosis	0.00079	0.00306	CcSEcCtD
Clofarabine—Infection—Lovastatin—atherosclerosis	0.000778	0.00302	CcSEcCtD
Clofarabine—Thrombocytopenia—Lovastatin—atherosclerosis	0.000767	0.00297	CcSEcCtD
Clofarabine—Arthralgia—Simvastatin—atherosclerosis	0.000764	0.00296	CcSEcCtD
Clofarabine—Myalgia—Simvastatin—atherosclerosis	0.000764	0.00296	CcSEcCtD
Clofarabine—Infection—Ezetimibe—atherosclerosis	0.000763	0.00296	CcSEcCtD
Clofarabine—Feeling abnormal—Rosuvastatin—atherosclerosis	0.000761	0.00295	CcSEcCtD
Clofarabine—Anxiety—Simvastatin—atherosclerosis	0.000761	0.00295	CcSEcCtD
Clofarabine—Tremor—Pravastatin—atherosclerosis	0.00076	0.00295	CcSEcCtD
Clofarabine—Gastrointestinal pain—Rosuvastatin—atherosclerosis	0.000755	0.00293	CcSEcCtD
Clofarabine—Nervous system disorder—Ezetimibe—atherosclerosis	0.000753	0.00292	CcSEcCtD
Clofarabine—Thrombocytopenia—Ezetimibe—atherosclerosis	0.000752	0.00292	CcSEcCtD
Clofarabine—Anaemia—Pravastatin—atherosclerosis	0.00075	0.00291	CcSEcCtD
Clofarabine—Anorexia—Lovastatin—atherosclerosis	0.000746	0.00289	CcSEcCtD
Clofarabine—Skin disorder—Ezetimibe—atherosclerosis	0.000746	0.00289	CcSEcCtD
Clofarabine—Leukopenia—Niacin—atherosclerosis	0.000738	0.00286	CcSEcCtD
Clofarabine—Oedema—Simvastatin—atherosclerosis	0.000732	0.00284	CcSEcCtD
Clofarabine—Abdominal pain—Rosuvastatin—atherosclerosis	0.00073	0.00283	CcSEcCtD
Clofarabine—Infection—Simvastatin—atherosclerosis	0.000728	0.00282	CcSEcCtD
Clofarabine—Leukopenia—Pravastatin—atherosclerosis	0.000726	0.00282	CcSEcCtD
Clofarabine—Cough—Niacin—atherosclerosis	0.000719	0.00279	CcSEcCtD
Clofarabine—Thrombocytopenia—Simvastatin—atherosclerosis	0.000717	0.00278	CcSEcCtD
Clofarabine—Musculoskeletal discomfort—Lovastatin—atherosclerosis	0.000713	0.00277	CcSEcCtD
Clofarabine—Cough—Pravastatin—atherosclerosis	0.000708	0.00275	CcSEcCtD
Clofarabine—Paraesthesia—Lovastatin—atherosclerosis	0.000703	0.00273	CcSEcCtD
Clofarabine—Myalgia—Niacin—atherosclerosis	0.000701	0.00272	CcSEcCtD
Clofarabine—Arthralgia—Niacin—atherosclerosis	0.000701	0.00272	CcSEcCtD
Clofarabine—Hypertension—Pravastatin—atherosclerosis	0.0007	0.00272	CcSEcCtD
Clofarabine—Musculoskeletal discomfort—Ezetimibe—atherosclerosis	0.0007	0.00271	CcSEcCtD
Clofarabine—Anorexia—Simvastatin—atherosclerosis	0.000698	0.00271	CcSEcCtD
Clofarabine—Dyspnoea—Lovastatin—atherosclerosis	0.000698	0.00271	CcSEcCtD
Clofarabine—Unspecified disorder of skin and subcutaneous tissue—Niacin—atherosclerosis	0.000697	0.0027	CcSEcCtD
Clofarabine—Arthralgia—Pravastatin—atherosclerosis	0.000691	0.00268	CcSEcCtD
Clofarabine—Myalgia—Pravastatin—atherosclerosis	0.000691	0.00268	CcSEcCtD
Clofarabine—Paraesthesia—Ezetimibe—atherosclerosis	0.00069	0.00267	CcSEcCtD
Clofarabine—Anxiety—Pravastatin—atherosclerosis	0.000688	0.00267	CcSEcCtD
Clofarabine—Dyspnoea—Ezetimibe—atherosclerosis	0.000685	0.00265	CcSEcCtD
Clofarabine—Hypersensitivity—Rosuvastatin—atherosclerosis	0.000681	0.00264	CcSEcCtD
Clofarabine—Decreased appetite—Lovastatin—atherosclerosis	0.000681	0.00264	CcSEcCtD
Clofarabine—Fatigue—Lovastatin—atherosclerosis	0.000675	0.00262	CcSEcCtD
Clofarabine—Oedema—Niacin—atherosclerosis	0.000672	0.00261	CcSEcCtD
Clofarabine—Pain—Lovastatin—atherosclerosis	0.00067	0.0026	CcSEcCtD
Clofarabine—Decreased appetite—Ezetimibe—atherosclerosis	0.000668	0.00259	CcSEcCtD
Clofarabine—Musculoskeletal discomfort—Simvastatin—atherosclerosis	0.000667	0.00259	CcSEcCtD
Clofarabine—Gastrointestinal disorder—Ezetimibe—atherosclerosis	0.000663	0.00257	CcSEcCtD
Clofarabine—Asthenia—Rosuvastatin—atherosclerosis	0.000663	0.00257	CcSEcCtD
Clofarabine—Oedema—Pravastatin—atherosclerosis	0.000662	0.00257	CcSEcCtD
Clofarabine—Fatigue—Ezetimibe—atherosclerosis	0.000662	0.00257	CcSEcCtD
Clofarabine—Infection—Pravastatin—atherosclerosis	0.000658	0.00255	CcSEcCtD
Clofarabine—Paraesthesia—Simvastatin—atherosclerosis	0.000658	0.00255	CcSEcCtD
Clofarabine—Pain—Ezetimibe—atherosclerosis	0.000657	0.00255	CcSEcCtD
Clofarabine—Tachycardia—Niacin—atherosclerosis	0.000656	0.00254	CcSEcCtD
Clofarabine—Pruritus—Rosuvastatin—atherosclerosis	0.000654	0.00253	CcSEcCtD
Clofarabine—Skin disorder—Niacin—atherosclerosis	0.000653	0.00253	CcSEcCtD
Clofarabine—Dyspnoea—Simvastatin—atherosclerosis	0.000653	0.00253	CcSEcCtD
Clofarabine—Hyperhidrosis—Niacin—atherosclerosis	0.00065	0.00252	CcSEcCtD
Clofarabine—Thrombocytopenia—Pravastatin—atherosclerosis	0.000648	0.00251	CcSEcCtD
Clofarabine—Feeling abnormal—Lovastatin—atherosclerosis	0.000645	0.0025	CcSEcCtD
Clofarabine—Anorexia—Niacin—atherosclerosis	0.000641	0.00249	CcSEcCtD
Clofarabine—Gastrointestinal pain—Lovastatin—atherosclerosis	0.00064	0.00248	CcSEcCtD
Clofarabine—Hyperhidrosis—Pravastatin—atherosclerosis	0.00064	0.00248	CcSEcCtD
Clofarabine—Decreased appetite—Simvastatin—atherosclerosis	0.000637	0.00247	CcSEcCtD
Clofarabine—Feeling abnormal—Ezetimibe—atherosclerosis	0.000633	0.00245	CcSEcCtD
Clofarabine—Gastrointestinal disorder—Simvastatin—atherosclerosis	0.000632	0.00245	CcSEcCtD
Clofarabine—Diarrhoea—Rosuvastatin—atherosclerosis	0.000632	0.00245	CcSEcCtD
Clofarabine—Fatigue—Simvastatin—atherosclerosis	0.000631	0.00245	CcSEcCtD
Clofarabine—Anorexia—Pravastatin—atherosclerosis	0.000631	0.00245	CcSEcCtD
Clofarabine—Hypotension—Niacin—atherosclerosis	0.000628	0.00244	CcSEcCtD
Clofarabine—Gastrointestinal pain—Ezetimibe—atherosclerosis	0.000628	0.00244	CcSEcCtD
Clofarabine—Pain—Simvastatin—atherosclerosis	0.000626	0.00243	CcSEcCtD
Clofarabine—Abdominal pain—Lovastatin—atherosclerosis	0.000619	0.0024	CcSEcCtD
Clofarabine—Body temperature increased—Lovastatin—atherosclerosis	0.000619	0.0024	CcSEcCtD
Clofarabine—Musculoskeletal discomfort—Niacin—atherosclerosis	0.000613	0.00238	CcSEcCtD
Clofarabine—Dizziness—Rosuvastatin—atherosclerosis	0.000611	0.00237	CcSEcCtD
Clofarabine—Body temperature increased—Ezetimibe—atherosclerosis	0.000607	0.00235	CcSEcCtD
Clofarabine—Abdominal pain—Ezetimibe—atherosclerosis	0.000607	0.00235	CcSEcCtD
Clofarabine—Paraesthesia—Niacin—atherosclerosis	0.000604	0.00234	CcSEcCtD
Clofarabine—Feeling abnormal—Simvastatin—atherosclerosis	0.000604	0.00234	CcSEcCtD
Clofarabine—Musculoskeletal discomfort—Pravastatin—atherosclerosis	0.000603	0.00234	CcSEcCtD
Clofarabine—Dyspnoea—Niacin—atherosclerosis	0.0006	0.00232	CcSEcCtD
Clofarabine—Gastrointestinal pain—Simvastatin—atherosclerosis	0.000599	0.00232	CcSEcCtD
Clofarabine—Somnolence—Niacin—atherosclerosis	0.000598	0.00232	CcSEcCtD
Clofarabine—Paraesthesia—Pravastatin—atherosclerosis	0.000595	0.00231	CcSEcCtD
Clofarabine—Dyspnoea—Pravastatin—atherosclerosis	0.00059	0.00229	CcSEcCtD
Clofarabine—Decreased appetite—Niacin—atherosclerosis	0.000585	0.00227	CcSEcCtD
Clofarabine—Rash—Rosuvastatin—atherosclerosis	0.000583	0.00226	CcSEcCtD
Clofarabine—Dermatitis—Rosuvastatin—atherosclerosis	0.000582	0.00226	CcSEcCtD
Clofarabine—Gastrointestinal disorder—Niacin—atherosclerosis	0.000581	0.00225	CcSEcCtD
Clofarabine—Abdominal pain—Simvastatin—atherosclerosis	0.000579	0.00224	CcSEcCtD
Clofarabine—Body temperature increased—Simvastatin—atherosclerosis	0.000579	0.00224	CcSEcCtD
Clofarabine—Headache—Rosuvastatin—atherosclerosis	0.000579	0.00224	CcSEcCtD
Clofarabine—Hypersensitivity—Lovastatin—atherosclerosis	0.000577	0.00224	CcSEcCtD
Clofarabine—Decreased appetite—Pravastatin—atherosclerosis	0.000576	0.00223	CcSEcCtD
Clofarabine—Pain—Niacin—atherosclerosis	0.000575	0.00223	CcSEcCtD
Clofarabine—Fatigue—Pravastatin—atherosclerosis	0.000571	0.00221	CcSEcCtD
Clofarabine—Pain—Pravastatin—atherosclerosis	0.000566	0.0022	CcSEcCtD
Clofarabine—Hypersensitivity—Ezetimibe—atherosclerosis	0.000566	0.00219	CcSEcCtD
Clofarabine—Asthenia—Lovastatin—atherosclerosis	0.000562	0.00218	CcSEcCtD
Clofarabine—Pruritus—Lovastatin—atherosclerosis	0.000554	0.00215	CcSEcCtD
Clofarabine—Asthenia—Ezetimibe—atherosclerosis	0.000551	0.00214	CcSEcCtD
Clofarabine—Gastrointestinal pain—Niacin—atherosclerosis	0.00055	0.00213	CcSEcCtD
Clofarabine—Nausea—Rosuvastatin—atherosclerosis	0.000549	0.00213	CcSEcCtD
Clofarabine—Feeling abnormal—Pravastatin—atherosclerosis	0.000546	0.00212	CcSEcCtD
Clofarabine—Pruritus—Ezetimibe—atherosclerosis	0.000543	0.00211	CcSEcCtD
Clofarabine—Gastrointestinal pain—Pravastatin—atherosclerosis	0.000541	0.0021	CcSEcCtD
Clofarabine—Hypersensitivity—Simvastatin—atherosclerosis	0.00054	0.00209	CcSEcCtD
Clofarabine—Diarrhoea—Lovastatin—atherosclerosis	0.000536	0.00208	CcSEcCtD
Clofarabine—Abdominal pain—Niacin—atherosclerosis	0.000532	0.00206	CcSEcCtD
Clofarabine—Body temperature increased—Niacin—atherosclerosis	0.000532	0.00206	CcSEcCtD
Clofarabine—Asthenia—Simvastatin—atherosclerosis	0.000525	0.00204	CcSEcCtD
Clofarabine—Diarrhoea—Ezetimibe—atherosclerosis	0.000525	0.00204	CcSEcCtD
Clofarabine—Abdominal pain—Pravastatin—atherosclerosis	0.000523	0.00203	CcSEcCtD
Clofarabine—Body temperature increased—Pravastatin—atherosclerosis	0.000523	0.00203	CcSEcCtD
Clofarabine—Pruritus—Simvastatin—atherosclerosis	0.000518	0.00201	CcSEcCtD
Clofarabine—Dizziness—Lovastatin—atherosclerosis	0.000518	0.00201	CcSEcCtD
Clofarabine—Dizziness—Ezetimibe—atherosclerosis	0.000508	0.00197	CcSEcCtD
Clofarabine—Diarrhoea—Simvastatin—atherosclerosis	0.000501	0.00194	CcSEcCtD
Clofarabine—Vomiting—Lovastatin—atherosclerosis	0.000498	0.00193	CcSEcCtD
Clofarabine—Hypersensitivity—Niacin—atherosclerosis	0.000495	0.00192	CcSEcCtD
Clofarabine—Rash—Lovastatin—atherosclerosis	0.000494	0.00191	CcSEcCtD
Clofarabine—Dermatitis—Lovastatin—atherosclerosis	0.000493	0.00191	CcSEcCtD
Clofarabine—Headache—Lovastatin—atherosclerosis	0.00049	0.0019	CcSEcCtD
Clofarabine—Vomiting—Ezetimibe—atherosclerosis	0.000488	0.00189	CcSEcCtD
Clofarabine—Hypersensitivity—Pravastatin—atherosclerosis	0.000488	0.00189	CcSEcCtD
Clofarabine—Dizziness—Simvastatin—atherosclerosis	0.000484	0.00188	CcSEcCtD
Clofarabine—Rash—Ezetimibe—atherosclerosis	0.000484	0.00188	CcSEcCtD
Clofarabine—Dermatitis—Ezetimibe—atherosclerosis	0.000484	0.00188	CcSEcCtD
Clofarabine—Asthenia—Niacin—atherosclerosis	0.000482	0.00187	CcSEcCtD
Clofarabine—Headache—Ezetimibe—atherosclerosis	0.000481	0.00187	CcSEcCtD
Clofarabine—Pruritus—Niacin—atherosclerosis	0.000476	0.00184	CcSEcCtD
Clofarabine—Asthenia—Pravastatin—atherosclerosis	0.000475	0.00184	CcSEcCtD
Clofarabine—Pruritus—Pravastatin—atherosclerosis	0.000468	0.00182	CcSEcCtD
Clofarabine—Vomiting—Simvastatin—atherosclerosis	0.000466	0.00181	CcSEcCtD
Clofarabine—Nausea—Lovastatin—atherosclerosis	0.000465	0.0018	CcSEcCtD
Clofarabine—Rash—Simvastatin—atherosclerosis	0.000462	0.00179	CcSEcCtD
Clofarabine—Dermatitis—Simvastatin—atherosclerosis	0.000461	0.00179	CcSEcCtD
Clofarabine—Diarrhoea—Niacin—atherosclerosis	0.00046	0.00178	CcSEcCtD
Clofarabine—Headache—Simvastatin—atherosclerosis	0.000459	0.00178	CcSEcCtD
Clofarabine—Nausea—Ezetimibe—atherosclerosis	0.000456	0.00177	CcSEcCtD
Clofarabine—Diarrhoea—Pravastatin—atherosclerosis	0.000453	0.00176	CcSEcCtD
Clofarabine—Dizziness—Niacin—atherosclerosis	0.000445	0.00172	CcSEcCtD
Clofarabine—Dizziness—Pravastatin—atherosclerosis	0.000438	0.0017	CcSEcCtD
Clofarabine—Nausea—Simvastatin—atherosclerosis	0.000435	0.00169	CcSEcCtD
Clofarabine—Vomiting—Niacin—atherosclerosis	0.000428	0.00166	CcSEcCtD
Clofarabine—Rash—Niacin—atherosclerosis	0.000424	0.00164	CcSEcCtD
Clofarabine—Dermatitis—Niacin—atherosclerosis	0.000424	0.00164	CcSEcCtD
Clofarabine—Headache—Niacin—atherosclerosis	0.000421	0.00163	CcSEcCtD
Clofarabine—Vomiting—Pravastatin—atherosclerosis	0.000421	0.00163	CcSEcCtD
Clofarabine—Rash—Pravastatin—atherosclerosis	0.000417	0.00162	CcSEcCtD
Clofarabine—Dermatitis—Pravastatin—atherosclerosis	0.000417	0.00162	CcSEcCtD
Clofarabine—Headache—Pravastatin—atherosclerosis	0.000415	0.00161	CcSEcCtD
Clofarabine—Nausea—Niacin—atherosclerosis	0.000399	0.00155	CcSEcCtD
Clofarabine—Nausea—Pravastatin—atherosclerosis	0.000393	0.00153	CcSEcCtD
Clofarabine—RRM1—E2F transcription factor network—SERPINE1—atherosclerosis	0.000371	0.0126	CbGpPWpGaD
Clofarabine—RRM1—Integrated Pancreatic Cancer Pathway—ESR2—atherosclerosis	0.000345	0.0117	CbGpPWpGaD
Clofarabine—ABCG2—HIF-2-alpha transcription factor network—SIRT1—atherosclerosis	0.00034	0.0115	CbGpPWpGaD
Clofarabine—POLA1—E2F transcription factor network—SIRT1—atherosclerosis	0.000338	0.0114	CbGpPWpGaD
Clofarabine—RRM2—E2F transcription factor network—SERPINE1—atherosclerosis	0.000306	0.0104	CbGpPWpGaD
Clofarabine—ABCG2—Fluoropyrimidine Activity—MTHFR—atherosclerosis	0.000295	0.01	CbGpPWpGaD
Clofarabine—ABCG2—Iron uptake and transport—HMOX1—atherosclerosis	0.00029	0.00983	CbGpPWpGaD
Clofarabine—RRM1—Integrated Pancreatic Cancer Pathway—SIRT1—atherosclerosis	0.000278	0.00941	CbGpPWpGaD
Clofarabine—POLA1—Integrated Pancreatic Cancer Pathway—CST3—atherosclerosis	0.000256	0.00868	CbGpPWpGaD
Clofarabine—RRM1—Integrated Pancreatic Cancer Pathway—FASLG—atherosclerosis	0.000248	0.00838	CbGpPWpGaD
Clofarabine—ABCG2—HIF-2-alpha transcription factor network—SERPINE1—atherosclerosis	0.000211	0.00713	CbGpPWpGaD
Clofarabine—RRM1—Integrated Pancreatic Cancer Pathway—ESR1—atherosclerosis	0.000209	0.00708	CbGpPWpGaD
Clofarabine—POLA1—E2F transcription factor network—SERPINE1—atherosclerosis	0.000209	0.00708	CbGpPWpGaD
Clofarabine—ABCG2—HIF-1-alpha transcription factor network—HMOX1—atherosclerosis	0.000206	0.00697	CbGpPWpGaD
Clofarabine—RRM1—Metabolism—LDLRAP1—atherosclerosis	0.000205	0.00695	CbGpPWpGaD
Clofarabine—POLA1—Integrated Pancreatic Cancer Pathway—ESR2—atherosclerosis	0.000194	0.00658	CbGpPWpGaD
Clofarabine—ABCG2—HIF-1-alpha transcription factor network—EDN1—atherosclerosis	0.000194	0.00657	CbGpPWpGaD
Clofarabine—RRM1—Metabolism—PLTP—atherosclerosis	0.000193	0.00654	CbGpPWpGaD
Clofarabine—RRM1—Integrated Pancreatic Cancer Pathway—IGF1—atherosclerosis	0.000181	0.00613	CbGpPWpGaD
Clofarabine—RRM2—Metabolism—LDLRAP1—atherosclerosis	0.000169	0.00573	CbGpPWpGaD
Clofarabine—RRM1—Metabolism—LTA4H—atherosclerosis	0.000167	0.00567	CbGpPWpGaD
Clofarabine—RRM1—Metabolism—ABCG8—atherosclerosis	0.000167	0.00567	CbGpPWpGaD
Clofarabine—RRM2—Metabolism—PLTP—atherosclerosis	0.000159	0.00538	CbGpPWpGaD
Clofarabine—DCK—Metabolism—LDLRAP1—atherosclerosis	0.000158	0.00535	CbGpPWpGaD
Clofarabine—ABCG2—HIF-1-alpha transcription factor network—LEP—atherosclerosis	0.000158	0.00535	CbGpPWpGaD
Clofarabine—POLA1—Integrated Pancreatic Cancer Pathway—SIRT1—atherosclerosis	0.000157	0.0053	CbGpPWpGaD
Clofarabine—RRM1—Integrated Pancreatic Cancer Pathway—PTGS2—atherosclerosis	0.00015	0.00508	CbGpPWpGaD
Clofarabine—DCK—Metabolism—PLTP—atherosclerosis	0.000149	0.00503	CbGpPWpGaD
Clofarabine—ABCG2—HIF-1-alpha transcription factor network—NOS2—atherosclerosis	0.000147	0.00498	CbGpPWpGaD
Clofarabine—ABCG2—HIF-2-alpha transcription factor network—VEGFA—atherosclerosis	0.000145	0.00491	CbGpPWpGaD
Clofarabine—POLA1—Integrated Pancreatic Cancer Pathway—FASLG—atherosclerosis	0.000139	0.00472	CbGpPWpGaD
Clofarabine—RRM2—Metabolism—ABCG8—atherosclerosis	0.000138	0.00467	CbGpPWpGaD
Clofarabine—RRM2—Metabolism—LTA4H—atherosclerosis	0.000138	0.00467	CbGpPWpGaD
Clofarabine—RRM1—Metabolism—ABCG1—atherosclerosis	0.000132	0.00448	CbGpPWpGaD
Clofarabine—RRM1—Integrated Pancreatic Cancer Pathway—NFKB1—atherosclerosis	0.00013	0.00441	CbGpPWpGaD
Clofarabine—DCK—Metabolism—ABCG8—atherosclerosis	0.000129	0.00436	CbGpPWpGaD
Clofarabine—DCK—Metabolism—LTA4H—atherosclerosis	0.000129	0.00436	CbGpPWpGaD
Clofarabine—RRM1—Integrated Pancreatic Cancer Pathway—MAPK8—atherosclerosis	0.000128	0.00434	CbGpPWpGaD
Clofarabine—RRM1—Metabolism—FABP4—atherosclerosis	0.000124	0.00421	CbGpPWpGaD
Clofarabine—RRM1—Metabolism—LCAT—atherosclerosis	0.000124	0.00421	CbGpPWpGaD
Clofarabine—ABCG2—HIF-1-alpha transcription factor network—SERPINE1—atherosclerosis	0.000124	0.0042	CbGpPWpGaD
Clofarabine—RRM1—Metabolism—APOA4—atherosclerosis	0.000122	0.00414	CbGpPWpGaD
Clofarabine—RRM1—Metabolism—CYP7A1—atherosclerosis	0.00012	0.00406	CbGpPWpGaD
Clofarabine—RRM1—Integrated Pancreatic Cancer Pathway—VEGFA—atherosclerosis	0.000118	0.00401	CbGpPWpGaD
Clofarabine—POLA1—Integrated Pancreatic Cancer Pathway—ESR1—atherosclerosis	0.000118	0.00399	CbGpPWpGaD
Clofarabine—ABCG2—Transmembrane transport of small molecules—ABCG4—atherosclerosis	0.000115	0.00389	CbGpPWpGaD
Clofarabine—RRM1—Integrated Pancreatic Cancer Pathway—MAPK3—atherosclerosis	0.000112	0.00379	CbGpPWpGaD
Clofarabine—RRM1—Metabolism—CYP27A1—atherosclerosis	0.000111	0.00376	CbGpPWpGaD
Clofarabine—ABCG2—Transmembrane transport of small molecules—ABCG8—atherosclerosis	0.00011	0.00373	CbGpPWpGaD
Clofarabine—RRM2—Metabolism—ABCG1—atherosclerosis	0.000109	0.00369	CbGpPWpGaD
Clofarabine—RRM1—Integrated Pancreatic Cancer Pathway—TGFB1—atherosclerosis	0.000109	0.00368	CbGpPWpGaD
Clofarabine—RRM1—Metabolism—ALOX5AP—atherosclerosis	0.000105	0.00356	CbGpPWpGaD
Clofarabine—RRM1—Metabolism—ALOX15—atherosclerosis	0.000105	0.00356	CbGpPWpGaD
Clofarabine—RRM1—Metabolism—APOA2—atherosclerosis	0.000105	0.00356	CbGpPWpGaD
Clofarabine—RRM1—Metabolism—PLA2G2A—atherosclerosis	0.000105	0.00356	CbGpPWpGaD
Clofarabine—RRM1—Metabolism—ABCG5—atherosclerosis	0.000104	0.00352	CbGpPWpGaD
Clofarabine—RRM2—Metabolism—LCAT—atherosclerosis	0.000102	0.00347	CbGpPWpGaD
Clofarabine—RRM2—Metabolism—FABP4—atherosclerosis	0.000102	0.00347	CbGpPWpGaD
Clofarabine—POLA1—Integrated Pancreatic Cancer Pathway—IGF1—atherosclerosis	0.000102	0.00345	CbGpPWpGaD
Clofarabine—DCK—Metabolism—ABCG1—atherosclerosis	0.000102	0.00345	CbGpPWpGaD
Clofarabine—RRM1—Integrated Pancreatic Cancer Pathway—TNF—atherosclerosis	0.000101	0.00343	CbGpPWpGaD
Clofarabine—RRM2—Metabolism—APOA4—atherosclerosis	0.000101	0.00341	CbGpPWpGaD
Clofarabine—RRM1—Metabolism—LPA—atherosclerosis	0.0001	0.0034	CbGpPWpGaD
Clofarabine—RRM2—Metabolism—CYP7A1—atherosclerosis	9.88e-05	0.00335	CbGpPWpGaD
Clofarabine—RRM1—Metabolism—BGN—atherosclerosis	9.71e-05	0.00329	CbGpPWpGaD
Clofarabine—RRM1—Metabolism—APOA5—atherosclerosis	9.62e-05	0.00326	CbGpPWpGaD
Clofarabine—DCK—Metabolism—FABP4—atherosclerosis	9.58e-05	0.00324	CbGpPWpGaD
Clofarabine—DCK—Metabolism—LCAT—atherosclerosis	9.58e-05	0.00324	CbGpPWpGaD
Clofarabine—DCK—Metabolism—APOA4—atherosclerosis	9.4e-05	0.00318	CbGpPWpGaD
Clofarabine—RRM1—Metabolism—PLA2G1B—atherosclerosis	9.26e-05	0.00313	CbGpPWpGaD
Clofarabine—DCK—Metabolism—CYP7A1—atherosclerosis	9.23e-05	0.00313	CbGpPWpGaD
Clofarabine—RRM2—Metabolism—CYP27A1—atherosclerosis	9.13e-05	0.00309	CbGpPWpGaD
Clofarabine—RRM1—Metabolism—ALOX5—atherosclerosis	8.94e-05	0.00303	CbGpPWpGaD
Clofarabine—ABCG2—Transmembrane transport of small molecules—ABCG1—atherosclerosis	8.7e-05	0.00295	CbGpPWpGaD
Clofarabine—RRM2—Metabolism—APOA2—atherosclerosis	8.66e-05	0.00293	CbGpPWpGaD
Clofarabine—RRM2—Metabolism—ALOX5AP—atherosclerosis	8.66e-05	0.00293	CbGpPWpGaD
Clofarabine—RRM2—Metabolism—ALOX15—atherosclerosis	8.66e-05	0.00293	CbGpPWpGaD
Clofarabine—RRM2—Metabolism—PLA2G2A—atherosclerosis	8.66e-05	0.00293	CbGpPWpGaD
Clofarabine—RRM2—Metabolism—ABCG5—atherosclerosis	8.55e-05	0.0029	CbGpPWpGaD
Clofarabine—DCK—Metabolism—CYP27A1—atherosclerosis	8.54e-05	0.00289	CbGpPWpGaD
Clofarabine—ABCG2—HIF-1-alpha transcription factor network—VEGFA—atherosclerosis	8.52e-05	0.00289	CbGpPWpGaD
Clofarabine—POLA1—Integrated Pancreatic Cancer Pathway—PTGS2—atherosclerosis	8.46e-05	0.00286	CbGpPWpGaD
Clofarabine—RRM2—Metabolism—LPA—atherosclerosis	8.26e-05	0.0028	CbGpPWpGaD
Clofarabine—DCK—Metabolism—ALOX15—atherosclerosis	8.09e-05	0.00274	CbGpPWpGaD
Clofarabine—DCK—Metabolism—ALOX5AP—atherosclerosis	8.09e-05	0.00274	CbGpPWpGaD
Clofarabine—DCK—Metabolism—APOA2—atherosclerosis	8.09e-05	0.00274	CbGpPWpGaD
Clofarabine—DCK—Metabolism—PLA2G2A—atherosclerosis	8.09e-05	0.00274	CbGpPWpGaD
Clofarabine—RRM1—Metabolism—NAMPT—atherosclerosis	8.02e-05	0.00271	CbGpPWpGaD
Clofarabine—RRM2—Metabolism—BGN—atherosclerosis	8e-05	0.00271	CbGpPWpGaD
Clofarabine—DCK—Metabolism—ABCG5—atherosclerosis	7.99e-05	0.00271	CbGpPWpGaD
Clofarabine—RRM1—Metabolism—LIPC—atherosclerosis	7.97e-05	0.0027	CbGpPWpGaD
Clofarabine—RRM1—Metabolism—APOC3—atherosclerosis	7.92e-05	0.00268	CbGpPWpGaD
Clofarabine—RRM2—Metabolism—APOA5—atherosclerosis	7.92e-05	0.00268	CbGpPWpGaD
Clofarabine—ABCG2—Transmembrane transport of small molecules—CYP7A1—atherosclerosis	7.89e-05	0.00267	CbGpPWpGaD
Clofarabine—RRM1—Metabolism—LDLR—atherosclerosis	7.87e-05	0.00266	CbGpPWpGaD
Clofarabine—DCK—Metabolism—LPA—atherosclerosis	7.72e-05	0.00261	CbGpPWpGaD
Clofarabine—RRM1—Metabolism—CETP—atherosclerosis	7.69e-05	0.0026	CbGpPWpGaD
Clofarabine—RRM2—Metabolism—PLA2G1B—atherosclerosis	7.62e-05	0.00258	CbGpPWpGaD
Clofarabine—RRM1—Integrated Pancreatic Cancer Pathway—AKT1—atherosclerosis	7.55e-05	0.00256	CbGpPWpGaD
Clofarabine—DCK—Metabolism—BGN—atherosclerosis	7.48e-05	0.00253	CbGpPWpGaD
Clofarabine—DCK—Metabolism—APOA5—atherosclerosis	7.4e-05	0.00251	CbGpPWpGaD
Clofarabine—RRM1—Metabolism—SCARB1—atherosclerosis	7.36e-05	0.00249	CbGpPWpGaD
Clofarabine—RRM2—Metabolism—ALOX5—atherosclerosis	7.36e-05	0.00249	CbGpPWpGaD
Clofarabine—POLA1—Integrated Pancreatic Cancer Pathway—NFKB1—atherosclerosis	7.34e-05	0.00249	CbGpPWpGaD
Clofarabine—POLA1—Integrated Pancreatic Cancer Pathway—MAPK8—atherosclerosis	7.22e-05	0.00244	CbGpPWpGaD
Clofarabine—DCK—Metabolism—PLA2G1B—atherosclerosis	7.12e-05	0.00241	CbGpPWpGaD
Clofarabine—ABCG2—Transmembrane transport of small molecules—TRPV1—atherosclerosis	7.09e-05	0.0024	CbGpPWpGaD
Clofarabine—RRM1—Metabolism—HMGCR—atherosclerosis	6.95e-05	0.00235	CbGpPWpGaD
Clofarabine—DCK—Metabolism—ALOX5—atherosclerosis	6.88e-05	0.00233	CbGpPWpGaD
Clofarabine—ABCG2—Transmembrane transport of small molecules—ABCG5—atherosclerosis	6.83e-05	0.00231	CbGpPWpGaD
Clofarabine—POLA1—Integrated Pancreatic Cancer Pathway—VEGFA—atherosclerosis	6.66e-05	0.00226	CbGpPWpGaD
Clofarabine—RRM2—Metabolism—NAMPT—atherosclerosis	6.6e-05	0.00224	CbGpPWpGaD
Clofarabine—RRM2—Metabolism—LIPC—atherosclerosis	6.56e-05	0.00222	CbGpPWpGaD
Clofarabine—RRM2—Metabolism—APOC3—atherosclerosis	6.52e-05	0.00221	CbGpPWpGaD
Clofarabine—RRM2—Metabolism—LDLR—atherosclerosis	6.48e-05	0.00219	CbGpPWpGaD
Clofarabine—RRM2—Metabolism—CETP—atherosclerosis	6.33e-05	0.00214	CbGpPWpGaD
Clofarabine—ABCG2—Metabolism—LDLRAP1—atherosclerosis	6.33e-05	0.00214	CbGpPWpGaD
Clofarabine—POLA1—Integrated Pancreatic Cancer Pathway—MAPK3—atherosclerosis	6.3e-05	0.00213	CbGpPWpGaD
Clofarabine—RRM1—Metabolism—ABCA1—atherosclerosis	6.2e-05	0.0021	CbGpPWpGaD
Clofarabine—DCK—Metabolism—NAMPT—atherosclerosis	6.17e-05	0.00209	CbGpPWpGaD
Clofarabine—DCK—Metabolism—LIPC—atherosclerosis	6.13e-05	0.00208	CbGpPWpGaD
Clofarabine—POLA1—Integrated Pancreatic Cancer Pathway—TGFB1—atherosclerosis	6.12e-05	0.00207	CbGpPWpGaD
Clofarabine—DCK—Metabolism—APOC3—atherosclerosis	6.09e-05	0.00206	CbGpPWpGaD
Clofarabine—RRM2—Metabolism—SCARB1—atherosclerosis	6.06e-05	0.00205	CbGpPWpGaD
Clofarabine—DCK—Metabolism—LDLR—atherosclerosis	6.06e-05	0.00205	CbGpPWpGaD
Clofarabine—ABCG2—Metabolism—PLTP—atherosclerosis	5.95e-05	0.00201	CbGpPWpGaD
Clofarabine—DCK—Metabolism—CETP—atherosclerosis	5.92e-05	0.002	CbGpPWpGaD
Clofarabine—RRM2—Metabolism—HMGCR—atherosclerosis	5.73e-05	0.00194	CbGpPWpGaD
Clofarabine—POLA1—Integrated Pancreatic Cancer Pathway—TNF—atherosclerosis	5.71e-05	0.00193	CbGpPWpGaD
Clofarabine—DCK—Metabolism—SCARB1—atherosclerosis	5.67e-05	0.00192	CbGpPWpGaD
Clofarabine—ABCG2—HIF-1-alpha transcription factor network—AKT1—atherosclerosis	5.44e-05	0.00184	CbGpPWpGaD
Clofarabine—DCK—Metabolism—HMGCR—atherosclerosis	5.35e-05	0.00181	CbGpPWpGaD
Clofarabine—RRM1—Metabolism—HMOX1—atherosclerosis	5.32e-05	0.0018	CbGpPWpGaD
Clofarabine—ABCG2—Metabolism—LTA4H—atherosclerosis	5.16e-05	0.00175	CbGpPWpGaD
Clofarabine—ABCG2—Metabolism—ABCG8—atherosclerosis	5.16e-05	0.00175	CbGpPWpGaD
Clofarabine—RRM2—Metabolism—ABCA1—atherosclerosis	5.1e-05	0.00173	CbGpPWpGaD
Clofarabine—RRM1—Metabolism—APOB—atherosclerosis	5.09e-05	0.00172	CbGpPWpGaD
Clofarabine—ABCG2—Transmembrane transport of small molecules—CETP—atherosclerosis	5.06e-05	0.00171	CbGpPWpGaD
Clofarabine—RRM1—Metabolism—GSTM1—atherosclerosis	4.95e-05	0.00168	CbGpPWpGaD
Clofarabine—RRM1—Metabolism—LPL—atherosclerosis	4.86e-05	0.00165	CbGpPWpGaD
Clofarabine—DCK—Metabolism—ABCA1—atherosclerosis	4.77e-05	0.00161	CbGpPWpGaD
Clofarabine—RRM1—Metabolism—GPX1—atherosclerosis	4.74e-05	0.00161	CbGpPWpGaD
Clofarabine—RRM1—Metabolism—CD36—atherosclerosis	4.62e-05	0.00156	CbGpPWpGaD
Clofarabine—RRM2—Cell Cycle, Mitotic—MAPK3—atherosclerosis	4.46e-05	0.00151	CbGpPWpGaD
Clofarabine—ABCG2—Transmembrane transport of small molecules—PLAT—atherosclerosis	4.46e-05	0.00151	CbGpPWpGaD
Clofarabine—RRM1—Metabolism—MTHFR—atherosclerosis	4.38e-05	0.00148	CbGpPWpGaD
Clofarabine—RRM2—Metabolism—HMOX1—atherosclerosis	4.38e-05	0.00148	CbGpPWpGaD
Clofarabine—RRM1—Metabolism—PPARA—atherosclerosis	4.3e-05	0.00145	CbGpPWpGaD
Clofarabine—POLA1—Integrated Pancreatic Cancer Pathway—AKT1—atherosclerosis	4.25e-05	0.00144	CbGpPWpGaD
Clofarabine—RRM2—Metabolism—APOB—atherosclerosis	4.19e-05	0.00142	CbGpPWpGaD
Clofarabine—RRM1—Metabolism—AGT—atherosclerosis	4.16e-05	0.00141	CbGpPWpGaD
Clofarabine—DCK—Metabolism—HMOX1—atherosclerosis	4.09e-05	0.00139	CbGpPWpGaD
Clofarabine—POLA1—Mitotic M-M/G1 phases—MAPK3—atherosclerosis	4.08e-05	0.00138	CbGpPWpGaD
Clofarabine—RRM2—Metabolism—GSTM1—atherosclerosis	4.08e-05	0.00138	CbGpPWpGaD
Clofarabine—RRM1—Metabolism—APOE—atherosclerosis	4.08e-05	0.00138	CbGpPWpGaD
Clofarabine—ABCG2—Metabolism—ABCG1—atherosclerosis	4.08e-05	0.00138	CbGpPWpGaD
Clofarabine—RRM1—Metabolism—CAV1—atherosclerosis	4.04e-05	0.00137	CbGpPWpGaD
Clofarabine—RRM1—Metabolism—APOA1—atherosclerosis	4.03e-05	0.00136	CbGpPWpGaD
Clofarabine—RRM2—Metabolism—LPL—atherosclerosis	4e-05	0.00136	CbGpPWpGaD
Clofarabine—RRM2—Cell Cycle—MAPK3—atherosclerosis	3.99e-05	0.00135	CbGpPWpGaD
Clofarabine—DCK—Metabolism—APOB—atherosclerosis	3.92e-05	0.00133	CbGpPWpGaD
Clofarabine—RRM2—Metabolism—GPX1—atherosclerosis	3.91e-05	0.00132	CbGpPWpGaD
Clofarabine—ABCG2—Metabolism—LCAT—atherosclerosis	3.83e-05	0.0013	CbGpPWpGaD
Clofarabine—ABCG2—Metabolism—FABP4—atherosclerosis	3.83e-05	0.0013	CbGpPWpGaD
Clofarabine—DCK—Metabolism—GSTM1—atherosclerosis	3.81e-05	0.00129	CbGpPWpGaD
Clofarabine—RRM2—Metabolism—CD36—atherosclerosis	3.8e-05	0.00129	CbGpPWpGaD
Clofarabine—ABCG2—Transmembrane transport of small molecules—PLG—atherosclerosis	3.79e-05	0.00128	CbGpPWpGaD
Clofarabine—ABCG2—Metabolism—APOA4—atherosclerosis	3.76e-05	0.00127	CbGpPWpGaD
Clofarabine—DCK—Metabolism—LPL—atherosclerosis	3.74e-05	0.00127	CbGpPWpGaD
Clofarabine—ABCG2—Metabolism—CYP7A1—atherosclerosis	3.7e-05	0.00125	CbGpPWpGaD
Clofarabine—RRM1—Metabolism—PIK3CG—atherosclerosis	3.68e-05	0.00125	CbGpPWpGaD
Clofarabine—DCK—Metabolism—GPX1—atherosclerosis	3.65e-05	0.00124	CbGpPWpGaD
Clofarabine—RRM2—Metabolism—MTHFR—atherosclerosis	3.61e-05	0.00122	CbGpPWpGaD
Clofarabine—DCK—Metabolism—CD36—atherosclerosis	3.56e-05	0.0012	CbGpPWpGaD
Clofarabine—RRM1—Metabolism—PPARG—atherosclerosis	3.55e-05	0.0012	CbGpPWpGaD
Clofarabine—RRM2—Metabolism—PPARA—atherosclerosis	3.54e-05	0.0012	CbGpPWpGaD
Clofarabine—ABCG2—Transmembrane transport of small molecules—HMOX1—atherosclerosis	3.5e-05	0.00118	CbGpPWpGaD
Clofarabine—RRM1—Metabolism—INS—atherosclerosis	3.48e-05	0.00118	CbGpPWpGaD
Clofarabine—RRM2—Metabolism—AGT—atherosclerosis	3.43e-05	0.00116	CbGpPWpGaD
Clofarabine—ABCG2—Metabolism—CYP27A1—atherosclerosis	3.42e-05	0.00116	CbGpPWpGaD
Clofarabine—DCK—Metabolism—MTHFR—atherosclerosis	3.37e-05	0.00114	CbGpPWpGaD
Clofarabine—RRM2—Metabolism—APOE—atherosclerosis	3.36e-05	0.00114	CbGpPWpGaD
Clofarabine—ABCG2—Transmembrane transport of small molecules—APOB—atherosclerosis	3.35e-05	0.00113	CbGpPWpGaD
Clofarabine—RRM2—Metabolism—CAV1—atherosclerosis	3.33e-05	0.00113	CbGpPWpGaD
Clofarabine—RRM2—Metabolism—APOA1—atherosclerosis	3.32e-05	0.00112	CbGpPWpGaD
Clofarabine—DCK—Metabolism—PPARA—atherosclerosis	3.31e-05	0.00112	CbGpPWpGaD
Clofarabine—ABCG2—Metabolism—ALOX15—atherosclerosis	3.24e-05	0.0011	CbGpPWpGaD
Clofarabine—ABCG2—Metabolism—PLA2G2A—atherosclerosis	3.24e-05	0.0011	CbGpPWpGaD
Clofarabine—ABCG2—Metabolism—APOA2—atherosclerosis	3.24e-05	0.0011	CbGpPWpGaD
Clofarabine—ABCG2—Metabolism—ALOX5AP—atherosclerosis	3.24e-05	0.0011	CbGpPWpGaD
Clofarabine—DCK—Metabolism—AGT—atherosclerosis	3.2e-05	0.00108	CbGpPWpGaD
Clofarabine—ABCG2—Metabolism—ABCG5—atherosclerosis	3.2e-05	0.00108	CbGpPWpGaD
Clofarabine—RRM1—Metabolism—ALB—atherosclerosis	3.19e-05	0.00108	CbGpPWpGaD
Clofarabine—DCK—Metabolism—APOE—atherosclerosis	3.14e-05	0.00106	CbGpPWpGaD
Clofarabine—DCK—Metabolism—CAV1—atherosclerosis	3.11e-05	0.00105	CbGpPWpGaD
Clofarabine—DCK—Metabolism—APOA1—atherosclerosis	3.1e-05	0.00105	CbGpPWpGaD
Clofarabine—ABCG2—Metabolism—LPA—atherosclerosis	3.09e-05	0.00105	CbGpPWpGaD
Clofarabine—RRM1—Metabolism—NOS3—atherosclerosis	3.05e-05	0.00103	CbGpPWpGaD
Clofarabine—POLA1—Cell Cycle, Mitotic—MAPK3—atherosclerosis	3.05e-05	0.00103	CbGpPWpGaD
Clofarabine—RRM2—Metabolism—PIK3CG—atherosclerosis	3.03e-05	0.00103	CbGpPWpGaD
Clofarabine—ABCG2—Metabolism—BGN—atherosclerosis	2.99e-05	0.00101	CbGpPWpGaD
Clofarabine—ABCG2—Metabolism—APOA5—atherosclerosis	2.96e-05	0.001	CbGpPWpGaD
Clofarabine—RRM2—Metabolism—PPARG—atherosclerosis	2.92e-05	0.00099	CbGpPWpGaD
Clofarabine—RRM2—Metabolism—INS—atherosclerosis	2.87e-05	0.000971	CbGpPWpGaD
Clofarabine—ABCG2—Metabolism—PLA2G1B—atherosclerosis	2.85e-05	0.000965	CbGpPWpGaD
Clofarabine—DCK—Metabolism—PIK3CG—atherosclerosis	2.83e-05	0.000958	CbGpPWpGaD
Clofarabine—ABCG2—Transmembrane transport of small molecules—PPARA—atherosclerosis	2.82e-05	0.000956	CbGpPWpGaD
Clofarabine—RRM1—Metabolism—PTGS2—atherosclerosis	2.79e-05	0.000946	CbGpPWpGaD
Clofarabine—ABCG2—Metabolism—ALOX5—atherosclerosis	2.75e-05	0.000932	CbGpPWpGaD
Clofarabine—DCK—Metabolism—PPARG—atherosclerosis	2.73e-05	0.000925	CbGpPWpGaD
Clofarabine—POLA1—Cell Cycle—MAPK3—atherosclerosis	2.73e-05	0.000924	CbGpPWpGaD
Clofarabine—DCK—Metabolism—INS—atherosclerosis	2.68e-05	0.000907	CbGpPWpGaD
Clofarabine—ABCG2—Transmembrane transport of small molecules—APOA1—atherosclerosis	2.65e-05	0.000897	CbGpPWpGaD
Clofarabine—RRM2—Metabolism—ALB—atherosclerosis	2.63e-05	0.00089	CbGpPWpGaD
Clofarabine—RRM2—Metabolism—NOS3—atherosclerosis	2.51e-05	0.000851	CbGpPWpGaD
Clofarabine—ABCG2—Metabolism—NAMPT—atherosclerosis	2.47e-05	0.000836	CbGpPWpGaD
Clofarabine—DCK—Metabolism—ALB—atherosclerosis	2.46e-05	0.000832	CbGpPWpGaD
Clofarabine—ABCG2—Metabolism—LIPC—atherosclerosis	2.45e-05	0.000831	CbGpPWpGaD
Clofarabine—ABCG2—Metabolism—APOC3—atherosclerosis	2.44e-05	0.000826	CbGpPWpGaD
Clofarabine—ABCG2—Metabolism—LDLR—atherosclerosis	2.42e-05	0.000821	CbGpPWpGaD
Clofarabine—ABCG2—Metabolism—CETP—atherosclerosis	2.37e-05	0.000802	CbGpPWpGaD
Clofarabine—DCK—Metabolism—NOS3—atherosclerosis	2.35e-05	0.000796	CbGpPWpGaD
Clofarabine—RRM2—Metabolism—PTGS2—atherosclerosis	2.3e-05	0.000779	CbGpPWpGaD
Clofarabine—ABCG2—Metabolism—SCARB1—atherosclerosis	2.27e-05	0.000768	CbGpPWpGaD
Clofarabine—DCK—Metabolism—PTGS2—atherosclerosis	2.15e-05	0.000728	CbGpPWpGaD
Clofarabine—ABCG2—Metabolism—HMGCR—atherosclerosis	2.14e-05	0.000725	CbGpPWpGaD
Clofarabine—ABCG2—Transmembrane transport of small molecules—ALB—atherosclerosis	2.1e-05	0.000711	CbGpPWpGaD
Clofarabine—ABCG2—Metabolism—ABCA1—atherosclerosis	1.91e-05	0.000646	CbGpPWpGaD
Clofarabine—ABCG2—Metabolism—HMOX1—atherosclerosis	1.64e-05	0.000554	CbGpPWpGaD
Clofarabine—ABCG2—Metabolism—APOB—atherosclerosis	1.57e-05	0.000531	CbGpPWpGaD
Clofarabine—ABCG2—Metabolism—GSTM1—atherosclerosis	1.53e-05	0.000517	CbGpPWpGaD
Clofarabine—ABCG2—Metabolism—LPL—atherosclerosis	1.5e-05	0.000507	CbGpPWpGaD
Clofarabine—ABCG2—Metabolism—GPX1—atherosclerosis	1.46e-05	0.000495	CbGpPWpGaD
Clofarabine—ABCG2—Metabolism—CD36—atherosclerosis	1.42e-05	0.000482	CbGpPWpGaD
Clofarabine—RRM1—Metabolism—AKT1—atherosclerosis	1.4e-05	0.000475	CbGpPWpGaD
Clofarabine—ABCG2—Metabolism—MTHFR—atherosclerosis	1.35e-05	0.000456	CbGpPWpGaD
Clofarabine—ABCG2—Metabolism—PPARA—atherosclerosis	1.32e-05	0.000448	CbGpPWpGaD
Clofarabine—ABCG2—Metabolism—AGT—atherosclerosis	1.28e-05	0.000434	CbGpPWpGaD
Clofarabine—ABCG2—Metabolism—APOE—atherosclerosis	1.26e-05	0.000425	CbGpPWpGaD
Clofarabine—ABCG2—Metabolism—CAV1—atherosclerosis	1.24e-05	0.000421	CbGpPWpGaD
Clofarabine—ABCG2—Metabolism—APOA1—atherosclerosis	1.24e-05	0.00042	CbGpPWpGaD
Clofarabine—RRM2—Metabolism—AKT1—atherosclerosis	1.16e-05	0.000391	CbGpPWpGaD
Clofarabine—ABCG2—Metabolism—PIK3CG—atherosclerosis	1.13e-05	0.000384	CbGpPWpGaD
Clofarabine—ABCG2—Metabolism—PPARG—atherosclerosis	1.09e-05	0.00037	CbGpPWpGaD
Clofarabine—DCK—Metabolism—AKT1—atherosclerosis	1.08e-05	0.000366	CbGpPWpGaD
Clofarabine—ABCG2—Metabolism—INS—atherosclerosis	1.07e-05	0.000363	CbGpPWpGaD
Clofarabine—ABCG2—Metabolism—ALB—atherosclerosis	9.83e-06	0.000333	CbGpPWpGaD
Clofarabine—ABCG2—Metabolism—NOS3—atherosclerosis	9.4e-06	0.000318	CbGpPWpGaD
Clofarabine—ABCG2—Metabolism—PTGS2—atherosclerosis	8.6e-06	0.000291	CbGpPWpGaD
Clofarabine—ABCG2—Metabolism—AKT1—atherosclerosis	4.32e-06	0.000146	CbGpPWpGaD
